Page last updated: 2024-11-05

ethyl caprylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ethyl caprylate, also known as ethyl octanoate, is an ester that occurs naturally in various fruits and is synthesized by the esterification of caprylic acid with ethanol. It has a pleasant, fruity odor and is commonly used as a flavoring agent in food and beverages. It is also used as a fragrance component in cosmetics and personal care products. Due to its low toxicity and volatility, it is used as a solvent in pharmaceutical applications. Ethyl caprylate is being investigated for its potential as a antimicrobial agent, particularly against bacteria and fungi. Its biological activity is attributed to its ability to disrupt cell membranes and interfere with bacterial growth. Studies have shown that ethyl caprylate can effectively inhibit the growth of certain pathogenic bacteria and fungi, making it a promising candidate for the development of new antimicrobial therapies. The compound is studied for its potential applications in various fields, including food preservation, wound healing, and the treatment of skin infections.'

ethyl octanoate : A fatty acid ethyl ester resulting from the formal condensation of octanoic acid with ethanol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7799
CHEMBL ID4633100
CHEBI ID87426
SCHEMBL ID454
MeSH IDM0546460

Synonyms (58)

Synonym
LS-13892
fema no. 2449
einecs 203-385-5
ethyl n-octanoate
brn 1754470
ethyl octylate
ai3-01977
caprylic acid ethyl ester
nsc 8898
ethyl octanoate (natural)
nsc-8898
nsc8898
ethyl octoate
wln: 7vo2
octanoic acid, ethyl ester
106-32-1
ethyl caprylate
ethyl octanoate
ethyl octanoate, >=98%, fcc, fg
ethyl octanoate, natural, >=98%, fcc, fg
ethyl octanoate, reagentplus(r), >=99%
caprylic acid ethylester
n-octanoic acid ethyl ester
O0030
AKOS000120258
octanoic acid ethyl ester
A801420
LMFA07010447
we(2:0/8:0)
unii-81c5mop582
81c5mop582 ,
FT-0631592
ethyl octanoate [fhfi]
ethyl octanoate [fcc]
ethyl caprylate [mi]
SCHEMBL454
CHEBI:87426
cas-106-32-1
NCGC00357039-01
dtxcid9030094
dtxsid8051542 ,
tox21_303730
ethyl ester of octanoic acid
n-caprylic acid ethyl ester
mfcd00009552
J-001572
ethyl octanoate, analytical reference material
ethyl octanoate, vetec(tm) reagent grade, 98%
octanoic acid-ethyl ester
octanoic acid ethyl ester (ethyl octanoate)
ethyl ester octanoic acid
fema 2449
Q3348790
EN300-21302
ethyloctanoate
CHEMBL4633100
CS-W016021
HY-W015305
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
fatty acid ethyl esterA fatty acid ester that is the carboxylic ester obtained by the formal condensation of a fatty acid with ethanol.
octanoate esterAny fatty acid ester in which the carboxylic acid component is octanoic acid (caprylic acid).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency38.57080.000714.592883.7951AID1259392
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1659751Agonist activity at TRPA1 (unknown origin) at 1000 uM relative to AITC2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Identification of a new class of non-electrophilic TRPA1 agonists by a structure-based virtual screening approach.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's13 (68.42)24.3611
2020's6 (31.58)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.40 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.43 (4.65)
Search Engine Demand Index44.07 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]